diabetestalk.net

Sell Medtronic Insulin Pump Supplies

Exit By Johnson & Johnson Bolsters Medtronic's Insulin Pump Dominance

Exit By Johnson & Johnson Bolsters Medtronic's Insulin Pump Dominance

Using an insulin pump is an act of profound trust. Diabetic patients wear their insulin pumps at virtually all hours, relying on the medical machinery to administer doses of a potentially lethal hormone to keep their blood-sugar levels from going dangerously out of range. So it came as a shock to Ed Komp when he learned last month that his pump maker, Johnson & Johnson (JNJ), was halting all North American sales of its Animas brand insulin pumps and pushing its customers toward devices and supplies made by Medtronic. Komp had dropped Medtronic a decade ago, choosing Animas pumps instead. Now he must reconsider his options after getting the Oct. 10 letter from JNJ. “My first response was really one of fear,” said Komp, a software engineer at the University of Kansas who has used insulin pumps to treat his Type 1 diabetes for 25 years. “I’ve made the change once, and it’s a really hard change, actually. Very small differences have a big impact for me personally.” Minnesota-run Medtronic has emerged as a major winner in the $1.7 billion U.S. market for insulin pumps and supplies, as thousands of letters limiting patient choice have been sent out to diabetics, from both manufacturers and insurers. Insulin pumps typically sell for between $4,000 and $8,000 and deliver small, frequent doses of insulin day and night, which typically benefits Type 1 diabetics, whose immune systems destroy insulin-producing cells. (Type 2 diabetes, involving insulin resistance, is typically treated with manual injections, rather than a pump.) Coverage policies at UnitedHealthcare and Medicare have given Medtronic a financial edge over other insulin pump makers, and Medtronic last year scored approval for the world’s only pump system that is designed to be able to automatically self Continue reading >>

Animas Stopped Selling Insulin Pumps In The Uk And Ireland

Animas Stopped Selling Insulin Pumps In The Uk And Ireland

Home IDDT News Animas stopped selling insulin pumps in the UK and Ireland Animas stopped selling insulin pumps in the UK and Ireland Animas, a leading manufacturer of insulin pumps has stopped making and selling insulin pumps in the UK and Ireland. The company, owned by Johnson and Johnson, announced in October 2017 that they were leaving the insulin pump business in the US. They will continue to offer pump support, providing pump supplies and upholding its warranty support for the Anima Vibe for a transition period. Pump supplies will be available until the end of the pumps 3-year warranty. The transition period gives people time to change to a different pump and Animas are recommending that people change to the Medtronic pump, although they do not have to change to this brand. Animas encourages users of the Animas Vibe with any questions to contact the Animas Customer Support team on 0800 0288039 (UK users) or 1800 812715 (Ireland users). Note: Animas has stated that the closing of their UK insulin pump business will not affect LifeScan (makers of the OneTouch blood glucose monitoring products), Dexcom (continuous glucose monitors) or Diasend (data sharing software) products. Continue reading >>

Animas To Discontinue Manufacturing And Sale Of Insulin Pumps

Animas To Discontinue Manufacturing And Sale Of Insulin Pumps

Animas Corporation has announced that it will discontinue the manufacturing and sale of Animas® Vibe® and OneTouch Ping® insulin pumps, close operations and exit the insulin pump business. Animas has selected Medtronic as its partner-of-choice to facilitate a seamless transition for patients, caregivers and healthcare providers. Patients using an Animas insulin pump will be offered the option to transfer to a Medtronic pump. Patient safety and continuity of care is of utmost importance and Animas will continue to provide customer service, training and warranty support, including providing pump supplies that are used in conjunction with the Animas® Vibe® and OneTouch Ping® insulin pumps, through a transition period. “We recognize that patients living with diabetes rely on our products to provide critical care, and we want to reassure them that we will be with them every step of the way throughout this transition,” said Valerie Asbury, General Manager of Animas Corporation. “Our number one priority is ensuring patients have a seamless experience as they transition to Medtronic. For over 30 years, Medtronic has been a global leader in the treatment of those living with diabetes, and we are confident they will provide outstanding support to our patients and their healthcare teams.” “We are incredibly grateful to our patients and healthcare partners for the trust, confidence and loyalty they have placed in Animas products over the last 12 years,” Asbury said. “With changing needs of customers, rapidly evolving market dynamics, and increased competitive pressures, it proved too difficult to sustain the insulin pump business and we decided to pursue an exit of the business. This decision was extremely difficult and comes following the extensive exploration Continue reading >>

Animas Closes Operations And Exits Insulin Pump Market

Animas Closes Operations And Exits Insulin Pump Market

By Adam Brown and Kelly Close What are the options for approximately 90,000 Animas pumpers worldwide and for others considering a new pump? What does it mean for the pump market and patient choice? On October 5, Johnson & Johnson (J&J) announced in disappointing news that Animas is closing operations and exiting the insulin pump market, affecting approximately 90,000 Animas pumpers worldwide. Click to Jump to FAQs: My warranty hasn’t expired yet. What can I do? My Animas pump warranty expires after September 30, 2019 (i.e., pump is 0-2 years old). What can I do? What pumps are currently available in the US? What is coming soon, especially with automated insulin delivery? Effective immediately in the US and Canada, Animas will no longer manufacture and sell the Vibe and OneTouch Ping insulin pumps, and will continue to offer supplies, customer service, training, and warranty support through a transition period. “Partner-of-choice” Medtronic will take over Animas supply reordering and support in the “next few months.” The companies will send an email with more details soon. We’d assume Animas’ exit is also coming very soon in other countries besides the US and Canada. For now, Animas pumpers can stay on their Animas pumps and continue to access supplies, and will need to decide what pump to move to next – see below for the different options between Medtronic, Insulet, and Tandem in the US, depending on preferences and warranty timing. For those who acquired an Animas pump in the last two years, a free upgrade is only available to Medtronic's less advanced MiniMed 630G pump. Read an open letter from The diaTribe Foundation about this decision here. Although the closing of the business is not unexpected – J&J has been considering a sale or partnership of t Continue reading >>

Johnson & Johnson Exits Insulin Pump Market Due To Increased Competition

Johnson & Johnson Exits Insulin Pump Market Due To Increased Competition

Animas Corporation, which is part of the Johnson & Johnson (J&J) Diabetes Care Companies, recently announced that it would close its doors and stop selling insulin pumps, including the Animas Vibe and OneTouch Ping, according to a press release. Animas reported they have selected Medtronic plc to help patients and providers with this transition. Patients who currently have an Animas pump will be offered a Medtronic pump, according to the release. The company plans to offer customer service, training, and warranty support during the transition period to ensure patients are achieving the optimal results. Additionally, patients will still be able to access supplies used with the pumps. “We recognize that patients living with diabetes rely on our products to provide critical care, and we want to reassure them that we will be with them every step of the way throughout this transition,” said Valerie Asbury, general manager of Animas. “Our number one priority is ensuring patients have a seamless experience as they transition to Medtronic. For over 30 years, Medtronic has been a global leader in the treatment of those living with diabetes, and we are confident they will provide outstanding support to our patients and their healthcare teams.” Currently, more than 90,000 patients use Animas pumps and products. The manufacturer advises that patients and providers should explore their transition options. “We are incredibly grateful to our patients and healthcare partners for the trust, confidence and loyalty they have placed in Animas products over the last 12 years,” Asbury said. “With changing needs of customers, rapidly evolving market dynamics, and increased competitive pressures, it proved too difficult to sustain the insulin pump business and we decided to pursu Continue reading >>

Medtronic Minimed Pump Supplies For Sale

Medtronic Minimed Pump Supplies For Sale

This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More. I recently switched from the Medtronic Minimed insulin pump to the Omnipod, and I was wondering if there are any of you good folks out there that would be interested in buying my Medtronic Quick-set Infusion sets (6mm, 23 inches) or my 1.8 ml Medtronic reservoirs. They are all perfectly fine and unopened, still in the box, not expired, and I have quite a few boxes of each. This is because Liberty Medical Supply Co. will not take them back since it has been over 30 days since they sent them to me, which sucks. I am an honest person, and I want to help other people, especially other diabetics out there that are in need for supplies. I tried listing on eBay, but their policy does not allow anything to be sold on their site that usually requires a prescription. If you are interested, please reply, and i can send you pictures via email if you would like. I can accept payment through Paypal only, to keep it safe, and I can ship all of this priority, so you would have it within 3 days. I hope some of you can help me while I help you. Even if you are not interested in buying these supplies, if you do know of a better way to sell these supplies online, let me know. Thank you in advance! Continue reading >>

Animas Shuts Down Its Pump Line

Animas Shuts Down Its Pump Line

Johnson & Johnson has decided to disconnect from the insulin pump market, a move that will leave Animas, Animas Vibe, and OneTouch Ping users looking for a new pump. A press release by the company said it has partnered with Medtronic to transition its existing customers to Medtronic’s pump line. Johnson & Johnson representatives cited increased competition as the reason the Animas brand has being discontinued. This news was first reported in the diabetes news sphere by Diabetes Mine on its Facebook page. sponsor The move to pull the plug on the Animas pump brand has long been seen as a possibility by market watchers, but outwardly Johnson & Johnson has professed a “business as usual” attitude with customers. When Diabetic Investor blogger David Kliff wrote about the possibility of consolidation in the insulin pump market in a February 2017 Diabetic Connect article, the company responded to the article by saying, “Animas continues to manufacture, deliver and support its products and provide the service our patients expect. We remain committed to our patients, and we intend to honor our warranty and do not anticipate any interruptions to patients’ pump therapy. If patients or potential patients have any concerns, they can contact Animas online or at 1-877-YES-PUMP.” That number’s phone tree now prompts customers to learn more about the decision to shudder the Animas pump line. I called the number and was connected with a call center operator who read a prepared statement about the transition. It said that customers whose warranties expire on or after September 30th, 2019 will have the option to transition to a Medtronic 630G free of charge; this Medtronic pump automatically suspends insulin delivery should the system’s CGM detect that blood glucose levels Continue reading >>

Customers In Countries Outside U.s. And Canada

Customers In Countries Outside U.s. And Canada

Animas Corporation intends to exit the insulin pump business and discontinue the manufacturing and sale of Animas® Vibe® and OneTouch Ping® insulin pumps. This decision was extremely difficult and comes following an extensive exploration of all viable other options for the Animas business. We have selected Medtronic as our partner-of-choice to facilitate a seamless insulin delivery system transition period. One of the reasons we chose Medtronic as our partner-of-choice is because of its strong track record providing outstanding patient care and support. For over 30 years, Medtronic has been a global leader in the treatment of those living with diabetes, and we are confident that they will provide outstanding support to our patients and their care teams. If you are currently using an Animas pump and pump supplies, you will continue to receive pump support and services. Specifically, Animas will continue to provide customer service and warranty support, including providing pump supplies that are used in conjunction with the Animas® Vibe® and OneTouch Ping® insulin pumps, through a transition period. As part of our continued commitment to patient care, Animas will honor pump warranties. We recognize that patients living with diabetes rely on our products to provide critical care, and we want to reassure patients and their care teams that we will be there, every step of the way, throughout this process. For patients, caregivers and healthcare providers in the U.S. and Canada, this announcement means: Animas has discontinued the sale of all Animas® Vibe® and OneTouch Ping® insulin pumps effective immediately. If you are on a pump with a warranty that expires on or after September 30, 2019, you or your pump supplier will be contacted by a member of the Medtronic tran Continue reading >>

Medtronic Service And Support For Animas Insulin Pump Customers

Medtronic Service And Support For Animas Insulin Pump Customers

As you may have read, this morning Animas announced its decision to close its insulin pump business, discontinuing the manufacturing and sale of all Animas® Vibe® and OneTouch Ping® insulin pumps in the US and Canada. In addition, Animas has selected Medtronic to be its partner-of-choice to support Animas customers through this time. Our top priority is to ensure that people using Animas pumps can stay on pump therapy and receive the supplies and support they need, while continuing to support our existing Medtronic customers. If you’re a Medtronic pumper, this does not impact you at all. You are, and always will be, invaluable members of our community. Whether you’ve been with us for 30 years or are a new addition to the family, we are inspired by you. You’re the reason we come to work every day excited to develop innovative products and services that help you live well and chase your dreams (whatever that may be). If you currently use an Animas insulin pump, I want to welcome you to the Medtronic family and assure you that we know the technology you use to manage your diabetes is an important, personal decision. We are here for you and committed to supporting you every step of the way. Nothing will change for you right away. However, here’s what this announcement means for you over the coming months: If your Animas pump is currently out of warranty, you can visit medtronicdiabetes.com/animas to explore your upgrade options. Please keep in mind that this arrangement does not impact Animas customers outside of the US or Canada at this time. It also does not impact those using OneTouch blood glucose meters. Again, please accept our warmest welcome to the Medtronic family. We’re honored to have the opportunity to extend to you the service and support that we Continue reading >>

Medtronic Is ‘only Game In Town’ For Insulin Pumps

Medtronic Is ‘only Game In Town’ For Insulin Pumps

What is an insulin pump? An insulin pump is a small machine worn on the body for many hours at a time that can give small doses of insulin for patients whose bodies don’t make enough of the hormone naturally. Pumps cost between $4,000 and $8,000 apiece. Since they often come with a four-year warranty, insurance companies typically will only pay for one pump every four years. < Medtronic’s MiniMed 670G Using an insulin pump is an act of profound trust. Diabetic patients wear their insulin pumps at virtually all hours, relying on the medical machinery to administer doses of a potentially lethal hormone to keep their blood-sugar levels from going dangerously out of range. So it came as a shock to Ed Komp when he learned last month that his pump maker, Johnson & Johnson (JNJ), was halting all North American sales of its Animas brand insulin pumps and pushing its customers toward devices and supplies made by Medtronic. Komp had dropped Medtronic a decade ago, choosing Animas pumps instead. Now he must reconsider his options after getting the Oct. 10 letter from JNJ. “My first response was really one of fear,” said Komp, a software engineer at the University of Kansas who has used insulin pumps to treat his Type 1 diabetes for 25 years. “I’ve made the change once, and it’s a really hard change, actually. Very small differences have a big impact for me personally.” Minnesota-run Medtronic has emerged as a major winner in the $1.7 billion U.S. market for insulin pumps and supplies, as thousands of letters limiting patient choice have been sent out to diabetics, from both manufacturers and insurers. Insulin pumps typically sell for between $4,000 and $8,000 and deliver small, frequent doses of insulin day and night, which typically benefits Type 1 diabetics, whos Continue reading >>

Why Doesn't Caremark Care About My Insulin Pump?

Why Doesn't Caremark Care About My Insulin Pump?

Christopher Elliott 23 Comments CAREMARK , CVS , PRESCRIPTION BENEFITS First, Caremark agrees to cover Ben Schwartzs insulin pump. Then it refuses. Is there anything he can do to make Caremark honor its word? Question: Caremark is not properly applying my familys prescription benefits, and customer service has not been able to resolve the issue. Between my wife and me, we have spoken to them three times and exchanged five secure messages. My wife is diabetic and uses an insulin pump. We had been getting her prescriptions filled at the local CVS pharmacy except for insulin pump supplies, which are not available at the local pharmacy and so were ordered through Caremark mail order (CVS is owned by Caremark). Our prescription plan includes a diabetic kit benefit where certain prescriptions can be filled at the same time for a single copay. I was assured it would be processed correctly. Late last year, my wife asked via Caremark.com Secure Message whether the insulin pump supplies qualified under the diabetes kit benefit. The customer service representative said that they did qualify and recommended that we transfer the prescriptions from the local pharmacy to the mail order pharmacy in order to take advantage of it, and we did so. When the order was filled, the diabetic kit benefit was not applied to any of the items. I called Caremark customer service and they resubmitted the order to have the benefits properly applied. The benefit was then applied to her test strips, but not the insulin pump supplies. I followed up by phone, providing the specific prescription numbers when requested by the representative, and was assured that it would be processed correctly. Related story: Help, my Lenovo laptop is cursed We have continued to follow up via Secure Message, each time reac Continue reading >>

Infusion Sets For Sale

Infusion Sets For Sale

I have about 50 boxes of Medtronic MiniMed Sof-Set Ultimate QR Infusion Sets for sale (individually or as a group). These are used for insulin pumps that use the luer lock connection. They are MMT-315 and come in a box of twelve. They expire in 2010 and all boxes are sealed. The length of the tubing is 42 inches and they have a quick disconnect on the tubing. The canula is 9mm and goes in at a 90 degree angle. I also have two of the inserters for the infusion sets. I have other miscellaneous diabetic supplies that I am selling too. I am no longer on an insulin pump so I do not need these supplies any more. The asking price for each box is $50.00, these boxes retail for approximately $140.00 each. If the item is shipped, I will charge only the actual shipping charge. Please feel free to call or email me with any questions. Thanks. [email protected] 316-554-0330 / 316-200-2147 Sorry, to have to mention this but I believe it is illegal to re-sell anything that is by prescription whether it be drugs, pumps and accessories, etc. in Kansas or any other state in the US. You and/or the person who purchases it can be charged. Continue reading >>

Newsflash: Roche Stops Selling Accu-chek Insulin Pumps In U.s.

Newsflash: Roche Stops Selling Accu-chek Insulin Pumps In U.s.

If you were hoping to buy a new Accu-Chek brand insulin pump from Roche Diabetes Care anytime soon, you're unfortunately out of luck. There's now one less player in the pump market, as the diabetes device company that makes the popular Accu-Chek brand of meters, test strips and insulin pumps has made the decision to stop selling pumps here in the United States -- at least for now. We learned about this when a CDE contacted us after an Accu-Chek rep apparently told her that Roche had "dropped out of the U.S. pump market," and this educator was surprised not to find any details on the company website. "This is not the way other pump companies have handled ceasing operations... and I wondered why. Do you have any back story?" she wrote us. Reaching out to Roche, spokeswoman Anne Gill confirmed that the company is not accepting any new pump customers as of Dec. 31, 2016, and explained: "At the end of the year, Roche Diabetes Care did re-prioritize our efforts in the U.S. with regards to our IDS (insulin delivery system) business. We are no longer proactively upgrading or acquiring new pump patients on our current system. Instead, we are concentrating our efforts on servicing our current Accu-Chek Spirit and Accu-Chek Combo patients." What Went Wrong? When we pressed for more detail, Gill shifted into marketing mode, saying how excited the company is about its new Accu-Chek Guide glucose monitor that was just FDA-approved last Fall and will go on sale this year. By not selling new pumps, she said, the company can focus on the launch for this Accu-Chek Guide system... wow, really?! It's a bit unclear whether this is a permenent decision, given that Gill tells us the company remains committed to bringing an array of "new innovations" here to the U.S. "This decision will not ha Continue reading >>

Animas To Cease Sale Of Insulin Pumps

Animas To Cease Sale Of Insulin Pumps

Animas Corporation, a Johnson & Johnson Diabetes Care company, announced it will discontinue the manufacturing and sale of its insulin pumps and close operations, exiting the insulin pump market, according to a company press release. Animas will partner with Medtronic to transfer its patients using the Animas Vibe and OneTouch Ping insulin pumps to a Medtronic pump. “We are incredibly grateful to our patients and health care partners for the trust, confidence and loyalty they have placed in Animas products over the last 12 years,” Valerie Asbury, general manager of Animas, said in the release. “With changing needs of customers, rapidly evolving market dynamics and increased competitive pressures, it proved too difficult to sustain the insulin pump business, and we decided to pursue an exit of the business. This decision was extremely difficult and comes following the extensive exploration of all other viable options for the Animas business.” About 90,000 people with diabetes are currently using Animas pumps. Patients, caregivers and health care providers can find more information at www.medtronicdiabtes.com/Animas. Continue reading >>

Onetouch Ping® Insulin Pump And Meter Remote

Onetouch Ping® Insulin Pump And Meter Remote

Say hello to the OneTouch Ping® Glucose Management System The OneTouch Ping® is the two-part system with one thing on its mind: helping you perform at your best. When used together with the OneTouch Ping® Insulin Pump, the Meter Remote communicates wirelessly to deliver insulin from the pump. Start the process to get your OneTouch Ping® System Our inside sales department will help you every step of the way. GET STARTED The OneTouch Ping® Meter Remote controls pump functions from up to 10 feet away, which means you can keep your OneTouch Ping® Insulin Pump under cover. With the OneTouch Ping®, you get great clinical performance* and features designed with your lifestyle in mind. Basal insulin keeps your blood sugar steady between meals. OneTouch Ping® System gives you a wide range of dosing options with a low basal insulin increment of 0.025 U/hr. Because how much you need is unique to you, OneTouch Ping® System precision is key. Superior post-meal control1‡ The bolus calculator designed by Animas delivers superior post-meal control compared to the Medtronic Paradigm® Bolus Wizard®. The bolus calculator in the OneTouch Ping® System automatically determines how much bolus insulin you may need to cover carbs eaten and/or correct a high BG. Pumpers using the automated bolus calculator in the OneTouch Ping® pump stayed in control longer—and closer to target range—than those using Medtronic Paradigm® Bolus Wizard® in a clinical study.1‡ Give yourself an insulin dose—and never touch your pump. The pump and Meter Remote can share information wirelessly, the Meter Remote can do more than just check your blood sugar. It is also able to control pump functions. Use it to calculate how much bolus insulin you need and tell your pump to deliver the dose, all w Continue reading >>

More in insulin